andrew kaczynski @KFILE
The same companies that make most lifesaving therapies largely ignore rare disease like infant brain cancer because the small number of patients offer no profit incentive - and these kids treatment options are limited. The gap is filled by funds like Team Beans. — PolitiTweet.org
